An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping

Kenta Kawasaki, Kohta Toshimitsu, Mami Matano, +33

Cell

Neuro-oncologyDevelopmental BiologyNeuroendocrine DisorderCerebral OrganoidNeuroendocrine Tumors +3

Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening

Toshiki Ebisudani, Shinya Sugimoto, Kei Haga, +12

Cell Reports

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma

Toshiki Ebisudani, Junko Hamamoto, Kazuhiro Togasaki, +25

Cell Reports

IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer

Tadashi Manabe, Hiroyuki Yasuda, Hideki Terai, +12

Molecular Cancer Research

Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer

Kota Ishioka, Hiroyuki Yasuda, Junko Hamamoto, +32

Cancer Research

Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model

Kei Haga, Reiko Takai‐Todaka, Yuta Matsumura, +17

PLoS Pathogens

VaccinationMucosal VaccinationVaccine DevelopmentNasal DeliveryAmplified Virus +13

Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study

Hideki Terai, Makoto Ishii, Ryo Takemura, +146

Respiratory Investigation

Epidemiological TrendLong CovidVirus EpidemiologyCovid-19 PandemicComprehensive Analysis +6

Pulmonary Tumor Thrombotic Microangiopathy Mimicking Inhalation Lung Injury

Akiko Tateishi, Kei Nakashima, Kazuei Hoshi, +4

Internal Medicine

Acute Lung InjuryPathologyPulmonary HypertensionOncologyPneumothorax +14

Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma

Taro Shinozaki, Kazuhiro Togasaki, Junko Hamamoto, +31

Nature Communications